David Bonita, Director at Loxo Oncology, holds 7.93M shares in Ikena Oncology (Ticker: IKNA), holds 20.82K shares in Acutus Medical (Ticker: AFIB), holds 10.65M shares in Prelude Therapeutics (Ticker: PRLD).
David Bonita latest transaction was an Uninformative Buy of ―.
What was David Bonita's most profitable transaction?
David Bonita’s most profitable transaction was an Informative Buy of VRAYQ stock on January 20, 2017. The return on the trade was 110.20%.
What is David Bonita's role in Loxo Oncology?
David Bonita's role in Loxo Oncology is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.